Dolby Laboratories (NYSE:DLB – Free Report) had its target price trimmed by Rosenblatt Securities from $85.00 to $80.00 in a research report sent to investors on Monday,Benzinga reports. The brokerage currently has a buy rating on the electronics maker’s stock.
Several other analysts also recently issued reports on DLB. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Finally, Zacks Research upgraded Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.00.
Check Out Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Stock Performance
Shares of NYSE:DLB opened at $61.13 on Monday. The business’s fifty day moving average price is $60.97 and its two-hundred day moving average price is $59.43. The stock has a market cap of $5.73 billion, a PE ratio of 26.01 and a beta of 0.79. Dolby Laboratories has a one year low of $48.26 and a one year high of $69.95.
Dolby Laboratories declared that its board has authorized a stock buyback program on Thursday, July 30th that allows the company to buy back $350 million in shares. This buyback authorization allows the electronics maker to repurchase up to 7% of its shares through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.
Insider Transactions at Dolby Laboratories
In other news, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total transaction of $450,666.26. Following the completion of the transaction, the senior vice president owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This represents a 4.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 16,517 shares of company stock worth $995,963. 37.93% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Dolby Laboratories
Institutional investors have recently bought and sold shares of the stock. Fulcrum Asset Management LLP boosted its holdings in shares of Dolby Laboratories by 733.7% in the 3rd quarter. Fulcrum Asset Management LLP now owns 1,434 shares of the electronics maker’s stock valued at $83,000 after purchasing an additional 1,262 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Dolby Laboratories by 130.1% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker’s stock valued at $85,000 after buying an additional 821 shares during the period. Nykredit A S purchased a new stake in shares of Dolby Laboratories during the 2nd quarter valued at $101,000. Hantz Financial Services Inc. increased its holdings in shares of Dolby Laboratories by 86.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,557 shares of the electronics maker’s stock worth $150,000 after buying an additional 1,182 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Dolby Laboratories during the 2nd quarter worth $216,000. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
More Dolby Laboratories News
Here’s some of the latest news about DLB:
- Positive Sentiment: Zacks Research slightly raised its FY2027 and FY2028 earnings-per-share estimates to $3.20 and $3.40, respectively, and nudged up forecasts for several 2027–2028 quarters. These modest upgrades offer a favorable signal on expected earnings, though the firm maintains a Hold rating. Dolby Laboratories analyst coverage
- Neutral Sentiment: Rosenblatt Securities lowered its price target to $80 from $85 but kept a Buy rating. The revised target still indicates substantial upside relative to the cited $61.13 share price, while the cut tempers the otherwise positive view. Rosenblatt Securities ratings
- Neutral Sentiment: Dolby is scheduled to report quarterly results, putting the focus on its performance and outlook. The earnings-preview coverage provided no specific results or forecast that would point clearly in either direction. Dolby Laboratories earnings preview
About Dolby Laboratories
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
